Dr. Kevin N. Heller is a distinguished physician-scientist and drug development executive with over 20 years of experience in oncology research and biopharmaceutical development. His career spans the complete drug development lifecycle from discovery through commercialization, with particular expertise in immuno-oncology, precision medicine, and regulatory strategy across academia and industry.